Luis
Montuenga Badía
Catedrático de Universidad
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red de Cáncer (38)
2024
-
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
Translational Research, Vol. 269, pp. 1-13
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment
Archivos de Bronconeumologia
-
Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (CEA) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles
Talanta, Vol. 266
2023
-
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Cancers, Vol. 15, Núm. 12
-
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Annals of Epidemiology, Vol. 77, pp. 1-12
-
Development of electrochemical immunosensor for quantitative detection of non-small cell lung cancer (NSCLC) biomaker YES1
Biosensors and Bioelectronics: X, Vol. 14
-
Estrogen Receptor and Immune Checkpoint Inhibitors: New Partners in Lung Cancer?
Clinical cancer research : an official journal of the American Association for Cancer Research
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
2022
-
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Cancer Letters, Vol. 529, pp. 70-84
-
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity
The Journal of experimental medicine, Vol. 219, Núm. 12
-
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System
Cancers, Vol. 14, Núm. 11
-
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer
Advanced Science, Vol. 9, Núm. 26
-
Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas
International Journal of Molecular Sciences, Vol. 23, Núm. 19
-
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
DMM Disease Models and Mechanisms, Vol. 15, Núm. 1
-
YES1 Is a Druggable Oncogenic Target in SCLC
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403
-
YES1: A Novel Therapeutic Target and Biomarker in Cancer
Molecular Cancer Therapeutics, Vol. 21, Núm. 9, pp. 1371-1380
-
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response
Journal of Hematology and Oncology, Vol. 15, Núm. 1
2021
-
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer
Translational Research, Vol. 233, pp. 77-91